238 related articles for article (PubMed ID: 28903838)
1. Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.
Chandolia B; Rajliwal JP; Bajpai M; Arora M
J Coll Physicians Surg Pak; 2017 Aug; 27(8):475-478. PubMed ID: 28903838
[TBL] [Abstract][Full Text] [Related]
2. Role of E-cadherin in Progression of Oral Squamous Cell Carcinoma: A Retrospective Immunohistochemical Study.
Gupta A; Sharma S; Batra M; Abidullah M; Bhuvinder S; Katragadda P
J Contemp Dent Pract; 2018 Sep; 19(9):1105-1110. PubMed ID: 30287712
[TBL] [Abstract][Full Text] [Related]
3. Loss of epithelial markers is an early event in oral dysplasia and is observed within the safety margin of dysplastic and T1 OSCC biopsies.
Abdalla Z; Walsh T; Thakker N; Ward CM
PLoS One; 2017; 12(12):e0187449. PubMed ID: 29216196
[TBL] [Abstract][Full Text] [Related]
4. [Morphology of epithelial-mesenchymal transformation in neoplasias of oral mucosa].
Ivina AA; Syomkin VA; Babichenko II
Stomatologiia (Mosk); 2017; 96(5):11-13. PubMed ID: 29072637
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
7. Presenilin 1/γ-secretase modulates P-cadherin processing and influences cell adhesion in oral squamous cell carcinoma cell lines.
Bauer K; Gosau M; Reinders J; Oefner P; Reichert TE; Bauer R
Carcinogenesis; 2013 Nov; 34(11):2622-8. PubMed ID: 23740836
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.
Zaid KW
Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis in oral epithelial dysplastic lesions and oral squamous cell carcinoma: A prognostic marker.
Nambiar S; Hegde V
Indian J Pathol Microbiol; 2016; 59(3):284-6. PubMed ID: 27510661
[TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a.
Upadhyay J; Rao NN; Upadhyay RB
J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280
[TBL] [Abstract][Full Text] [Related]
11. P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.
Lo Muzio L; Pannone G; Mignogna MD; Staibano S; Mariggiò MA; Rubini C; Procaccini M; Dolci M; Bufo P; De Rosa G; Piattelli A
Histol Histopathol; 2004 Oct; 19(4):1089-99. PubMed ID: 15375751
[TBL] [Abstract][Full Text] [Related]
12. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indicatior of poor prognosis.
Muñoz-Guerra MF; Marazuela EG; Fernández-Contreras ME; Gamallo C
Cancer; 2005 Mar; 103(5):960-9. PubMed ID: 15685613
[TBL] [Abstract][Full Text] [Related]
13. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
14. Changed expression of E-cadherin and galectin-9 in oral squamous cell carcinomas but lack of potential as prognostic markers.
Chan SW; Kallarakkal TG; Abraham MT
Asian Pac J Cancer Prev; 2014; 15(5):2145-52. PubMed ID: 24716948
[TBL] [Abstract][Full Text] [Related]
15. Expression of E- Cadherin and Levels of Dysplasia in Oral Leukoplakia - A Prospective Cohort Study.
Sathish II; Asokan K; C L K; Ramanathan A
Asian Pac J Cancer Prev; 2020 Feb; 21(2):405-410. PubMed ID: 32102518
[TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: an immunohistochemical study.
Kaur G; Carnelio S; Rao N; Rao L
Indian J Dent Res; 2009; 20(1):71-6. PubMed ID: 19336864
[TBL] [Abstract][Full Text] [Related]
17. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance.
Prgomet Z; Andersson T; Lindberg P
Eur J Oral Sci; 2017 Aug; 125(4):237-246. PubMed ID: 28603941
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evaluation of E-cadherin in oral epithelial dysplasia and squamous cell carcinoma.
Sharma J; Bhargava M; Aggarwal S; Aggarwal A; Varshney A; Chopra D
Indian J Pathol Microbiol; 2022; 65(4):755-760. PubMed ID: 36308176
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin and vimentin in oral squamous cell carcinoma.
Zhou J; Tao D; Xu Q; Gao Z; Tang D
Int J Clin Exp Pathol; 2015; 8(3):3150-4. PubMed ID: 26045832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
